MIZUHO MEDY CO LTD revenue for the last year amounted to 10.99 B JPY, the most of which — 7.62 B JPY — came from its highest performing source at the moment, Hospitals and Practitioner - New Coronavirus Test Drug, the year earlier bringing 15.18 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought MIZUHO MEDY CO LTD 10.99 B JPY, and the year before that — 17.58 B JPY.